Actor Arshad Warsi revealed he quit smoking in just one week after 35 years using a mobile app that helped “rewire” his ...

American Heart Association argues that South Carolina bill H.4303 would benefit the tobacco industry at the expense of public ...

Although mental disorders have multifactorial causes, genetics can explain some of them, yet this field remains largely unexplored in terms of guiding ...

Shame and food insecurity are well-established risk factors for depression, anxiety, and disordered eating. Eating disorders increase mortality risk by nearly five times, far surpassing the mortality ...

It has crept up so silently, many parents won’t even know it exists. But this new form of nicotine is definitely cause for concern. Georgina Heffernan writes. Every parent in Ireland knows the routine ...

Growing medical evidence suggests medicines developed to treat diabetes and obesity may also reshape the brain’s response to ...

Women face biological, hormonal, and psychosocial factors that complicate smoking cessation, prompting experts to call for sex-specific strategies to improve quit success.

A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.

The agency is proposing allowing other tastes for vapes, like mint, coffees, spices or tea, to appeal to adults. At the same time, illicit candy-flavored types aimed at teenagers have flooded the ...

In veterans with type 2 diabetes, treatment with GLP-1 receptor agonists was associated with a reduced risk for various substance use disorders compared with sodium-glucose cotransporter-2, or SGLT-2, ...

Learn about the impact of tobacco on Black communities and the efforts to promote smoke-free living and community care at the Faith in Health Collaborative Summit.

A study in The BMJ found GLP-1 drugs used for diabetes and obesity may also curb addiction by reducing cravings. Researchers ...